News & Views | Published:

Building a staircase to precision medicine for biliary tract cancer

Nature Genetics volume 47, pages 967968 (2015) | Download Citation

A new study has conducted a comprehensive exome and transcriptome analysis of a large number of intrahepatic, perihilar and distal cholangiocarcinomas and gallbladder cancers in Japanese patients. This study identifies many new alterations, confirms genetic differences in these distinct subtypes of biliary tract cancer and demonstrates that approximately 40% of described genetic aberrations are potentially targetable.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Lancet 383, 2168–2179 (2014).

  2. 2.

    et al. Gastroenterology 144, 829–840 (2013).

  3. 3.

    et al. Hum. Pathol. 40, 834–842 (2009).

  4. 4.

    et al. Nat. Genet. 44, 690–693 (2012).

  5. 5.

    et al. PLoS ONE 9, e115383 (2014).

  6. 6.

    et al. Hepatology 59, 1427–1434 (2014).

  7. 7.

    et al. Nat. Genet. 47, 1003–1010 (2015).

  8. 8.

    et al. Cancer Discov. 3, 636–647 (2013).

  9. 9.

    et al. PLoS Genet. 10, e1004135 (2014).

  10. 10.

    et al. Science 343, 1010–1014 (2014).

  11. 11.

    et al. Nat. Commun. 4, 2218 (2013).

Download references

Author information

Affiliations

  1. Nataliya Razumilava is in the Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.

    • Nataliya Razumilava
  2. Gregory J. Gores is in the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

    • Gregory J Gores

Authors

  1. Search for Nataliya Razumilava in:

  2. Search for Gregory J Gores in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Gregory J Gores.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ng.3386

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing